首页> 外国专利> PHARMACEUTICAL COMPOSITION; USE OF AT LEAST ONE NON-IONIC CELLULOSE ETHER; METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION; METHOD FOR TREATING AND / OR PREVENTING A CLIMATE CLIMATE; USE OF A PHARMACEUTICAL COMPOSITION; AND KIT

PHARMACEUTICAL COMPOSITION; USE OF AT LEAST ONE NON-IONIC CELLULOSE ETHER; METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION; METHOD FOR TREATING AND / OR PREVENTING A CLIMATE CLIMATE; USE OF A PHARMACEUTICAL COMPOSITION; AND KIT

机译:药物成分;至少使用一种非离子纤维素醚;制备药物组合物的方法;治疗和/或预防气候变化的方法;药物成分的使用;和套件

摘要

Pharmaceutical composition The present invention relates to an innovative pharmaceutical composition comprising oxytocin and / or one or more fragments and / or variants thereof and at least one nonionic cellulose ether as hydroxypropyl methylcellulose. that said pharmaceutical composition has a low ph. The present pharmaceutical composition has been shown to provide an exceptionally suitable environment for oxytocin as the stability of the oxytocin has increased significantly compared to prior compositions with such a molecule. The pharmaceutical composition according to the invention may be used for medical purposes as in the treatment of climatic disorders.
机译:药物组合物本发明涉及一种创新的药物组合物,其包含催产素和/或其一个或多个片段和/或变体,以及至少一种非离子性纤维素醚作为羟丙基甲基纤维素。所述药物组合物具有低ph。已经显示出本发明的药物组合物为催产素提供了非常合适的环境,因为与具有这种分子的现有组合物相比,催产素的稳定性已经显着提高。根据本发明的药物组合物可以用于医学目的,如治疗气候疾病。

著录项

  • 公开/公告号BR112013026153A2

    专利类型

  • 公开/公告日2019-09-17

    原文格式PDF

  • 申请/专利权人 PEP-TONIC MEDICAL AB;

    申请/专利号BR20131126153

  • 发明设计人 ANDERS CARLSSON;KERSTIN UVNÄS-MOBERG;

    申请日2012-04-13

  • 分类号A61P15/12;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号